From an Enterprise to an Era

May 19 – 20, 2022 • Ritz-Carlton Laguna Niguel, Dana Point, CA

2022 Organizing Committee

The Annual Personalized Medicine Conference is organized by a cross-industry, cross-disciplinary panel, made up of providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.


Chair

EDWARD ABRAHAMS, PH.D.
President, Personalized Medicine Coalition

Bonnie J. Addario
Co-Founder, Board Chair, GO2 Foundation for Lung Cancer

Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)

Mandy Bazile
Senior Director, Public Policy and Reimbursement, Genentech

Mary Bordoni
Director, Strategic Alliance Development, Federal Government Affairs, Bristol Myers Squibb

William Dalton, Ph.D., M.D.
Founder, Senior Advisor, M2Gen

Stephen L. Eck, M.D., Ph.D.
Senior Vice President, Clinical Development, Chief Medical Officer, MacroGenics

Okan Ekinci, M.D.
Senior Vice President, Global Head of Marketing and Innovation, Roche Diagnostics Information Solutions

Lori Frank, Ph.D.
Senior Vice President, Research, Policy, and Programs, The New York Academy of Medicine; Medical, Scientific, and Memory Screening Advisory Board Member, Alzheimer’s Foundation of America

Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator

Kris Joshi, Ph.D.
Executive Vice President, President, Network Solutions, Change Healthcare

Richard Knight
President, American Association of Kidney Patients

Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Experimental Medicine, GlaxoSmithKline

Susan McClure
Founder, CEO, Genome Creative

Howard McLeod, Pharm.D.
Executive Clinical Director, Precision Health, Intermountain Healthcare

Tom Miller
Founder, Managing Partner, GreyBird Ventures

Lincoln Nadauld, M.D., Ph.D.
Vice President, Chief of Precision Health and Academics, Intermountain Healthcare

Michael J. Pellini, M.D.
Managing Partner, Section 32

Ammar Qadan
Vice President, Global Head of Market Access, Illumina

Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Pfizer

Michael Sherman, M.D.
Executive Vice President, Chief Medical Officer, Point32Health

Lauren Silvis
Senior Vice President, External Affairs, Tempus

Ralph Snyderman, M.D.
James B. Duke Distinguished Professor of Medicine, Duke University

Mark P. Stevenson
Board Member, Personalized Medicine Coalition

Bernadette Toner
CEO, GenomeWeb

Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, The University of Texas MD Anderson Cancer Center

Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting

Werner Verbiest
Strategic Partnerships and Alliances Leader, Janssen Pharmaceutical Companies of Johnson & Johnson

Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Research and Development, Medical, Population Health, Quest Diagnostics